Angular invests in deep technology that is purchased by sophisticated buyers - usually large enterprises. Within that category, the firm is vertically and horizontally agnostic. We will look at technologies in wide range of verticals. While most of our investments have been in more "traditional" areas of enterprise software (horizontal and vertical applications, IT infrastructure, data technologies, security, etc.), we are absolutely open to consider investments in other spaces such as food, water, energy, space, automotive, digital health, synthetic biology, genomics, and other areas.
That said, while Angular will invest in (and has invested in) digital health and healthcare IT, the firm does not invest in medical technologies. If you are developing a pharmaceutical or building a diagnostic or therapeutic device, it's not for us.
For more on our sector focus, please see this blog post.